Sulfinpyrazone

磺吡酮

Report date: 2022/01/24 17:28:06
NME

Base Information

Drug NameSulfinpyrazone
Drug Alias NameSulfinpyrazonum硫氧唑酮苯磺唑酮SulfinpirazonaSulphinpyrazone +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUric acid inhibitors
TargetsUric acid
Therapy Area/IndicationsArthritis, Gouty
Global Approved IndicationsArthritis, Gouty
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1959/05/13
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsArthritis, Gouty

Other Information

ATC CodeM04AB02
Related LinksWikipediaDrugBankKEGG